Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer.

ABSTRACT:

SUBMITTER: Guan X 

PROVIDER: S-EPMC10025258 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature